|4Mar 27, 6:05 PM ET

Goodman Tony 4

4 · ADIAL PHARMACEUTICALS, INC. · Filed Mar 27, 2024

Insider Transaction Report

Form 4
Period: 2024-03-25
Goodman Tony
DirectorChief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-25+42,00042,000 total
    Exercise: $1.35Exp: 2034-03-24Common Stock (42,000 underlying)
Footnotes (1)
  • [F1]The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary